Want to join the conversation?
Specialty biopharmaceutical company $MNK reported a jump in 1Q16 earnings driven by higher sales and profits from recently acquired assets in the Specialty Brands segment. Net income rose to $211.1MM or $1.82 per share from $92.7MM or $0.79 per share last year. Net sales grew 20.3% to $914.8MM. Adjusted EPS increased 16.8% to $2.09.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!